What are the odds of disability from untreated infant hip dysplasia?
Evidence quality 4.5/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 3/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 5/5
- D4 Uncertainty
- 4/5
- D5 Scope
- 5/5
- D6 Prose
- 5/5
- D7 Perception honesty
- 4/5
- D8 Caveat completeness
- 5/5
Lifetime probability · lifetime, US adult
1 in 5,000
0.02% lifetime chance
range 1 in 10,000 to 1 in 2,000
● your factors — click this risk ▾ to reveal
≈ As likely as
Perceived
Developmental dysplasia of the hip (DDH) is a well-known pediatric screening target, and the fear surrounding it is largely justified — but directed at the wrong node. Parents often fear the condition itself, when the actual risk is missing the diagnosis. Universal newborn screening (clinical examination at birth, selective or universal ultrasound depending on the country) catches the vast majority of cases. The residual fear is about the subset of infants whose dysplasia is missed by screening and progresses silently to early degenerative arthritis. This fear is calibrated: missed DDH has genuinely severe consequences, but the probability of missing it in a screened population is low.
Rough estimate: Parents often fear severe disability; the real question is the probability of missed diagnosis
Source: editorial intuition, not polled
Actual
~1-3 per 1,000 newborns have clinically significant DDH; ~0.1-0.3 per 1,000 are missed by screening
US newborns undergoing standard clinical hip screening (Ortolani/Barlow)
Show derivation
DDH prevalence ranges from 1-30 per 1,000 depending on definition and screening method. Clinically significant DDH requiring treatment affects roughly 1-3 per 1,000 live births. In populations with clinical screening (Ortolani/Barlow at birth, as in the US), the late-presentation rate (diagnosis after 3-6 months) is approximately 0.1-0.3 per 1,000. Countries using universal ultrasound screening (e.g., Austria, Germany) report even lower late-presentation rates (~0.03-0.1 per 1,000). Among late-presenting cases, the probability of significant disability (early hip replacement, chronic pain, gait abnormality) is high — DDH accounts for 21-29% of total hip replacements in young adults (under 50). However, this represents cumulative decades of undiagnosed cases, not a single-year incidence. For the normalized estimate: ~0.2 per 1,000 screened births experience missed DDH, and of those, roughly all develop some degree of early degenerative change. Over a US birth cohort, this yields approximately 1 in 5,000 adults living with disability attributable to missed DDH. This is a prevalence-based lifetime estimate.
Caveats: This entry normalizes to the probability of disability from MISSED DDH in a scre…
This entry normalizes to the probability of disability from MISSED DDH in a screened population. The condition itself is common (~1-3 per 1,000), but screening catches the vast majority and early treatment (Pavlik harness) is highly effective. The residual risk of disability applies to the small subset of cases missed by screening — approximately 0.1-0.3 per 1,000 in the US clinical screening model. Countries with universal ultrasound screening (Austria, Germany, Switzerland) report lower late-presentation rates. The fear is therefore calibrated: it is rational to be concerned about DDH screening quality, but the absolute probability of a screened infant developing DDH-related disability is very low. Breech presentation, female sex, and family history are the major risk factors that should trigger heightened screening vigilance.
Risks at similar odds
Other risks with roughly the same likelihood — useful for calibration.
Magnet ingestion
What are the odds of a child swallowing multiple high-powered magnets and needing hospitalization?
Laundry pod ingestion
What are the odds of a toddler suffering a serious injury from swallowing or squeezing a laundry detergent pod?
Untreated childhood scoliosis
What are the odds of serious disability from untreated childhood scoliosis?
Untreated childhood flat feet
What are the odds of lasting harm from not treating childhood flat feet?
Child bike trailer
What are the odds of serious injury to a child riding in a towed bicycle trailer?
Child rear bike seat
What are the odds of serious injury to a child riding in a rear-mounted bike seat?
Recently viewed on this device
Stored locally — clear anytime.
Pick challenger
Developmental dysplasia of the hip affects roughly 1-3 per 1,000 newborns at a level requiring treatment, though neonatal hip instability of any degree is far more common (1-1.5% of births). The crucial fact is that 90% of neonatal hip instability resolves spontaneously without intervention, and among the cases that do require treatment, early detection changes the calculus entirely. A Pavlik harness initiated before three months of age succeeds in over 90% of cases, with residual dysplasia rates under 3%. The fear surrounding DDH is therefore not about the condition itself — it is about the screening system’s ability to catch it before the treatment window narrows.
The consequences of genuinely missed DDH are severe. Undiagnosed dysplasia leads to abnormal hip joint mechanics, accelerated cartilage wear, and premature osteoarthritis, with many patients requiring total hip replacement in their 30s or 40s. DDH accounts for 21-29% of all hip replacements performed on adults under 50. But this statistic reflects cumulative decades of missed cases across eras with less systematic screening. In contemporary US practice, where clinical hip examination (Ortolani and Barlow maneuvers) is standard at birth and well-child visits, the late-presentation rate — diagnosis after 3-6 months — is approximately 0.1-0.3 per 1,000 births. Countries using universal ultrasound screening (Austria, Germany) report even lower rates of missed cases.
The screening debate itself is instructive. The US uses selective ultrasound screening (imaging only for high-risk infants: breech, female, family history), while several European countries screen every newborn with ultrasound. The evidence on whether universal ultrasound reduces late-presenting DDH is mixed — it increases detection of mild dysplasia that would resolve spontaneously, potentially leading to overtreatment. The risk factors that matter most are breech presentation (6-fold increase), female sex (4-fold), and family history (5-fold). For an infant with none of these factors who passes clinical examination, the probability of missed DDH progressing to disability is vanishingly small. The parental anxiety tends to be generic — “what if something is wrong with my baby’s hips” — rather than calibrated to the actual screening architecture, which is designed precisely to catch the cases where the fear is warranted.
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
-
[1] StatPearls (NCBI Bookshelf) — Developmental Dysplasia of the Hip
Developmental Dysplasia of the Hip- Statistic
DDH incidence 1-1.5%; hip instability in 5/1,000 boys and 13/1,000 girls; 90% of neonatal hip instability resolves spontaneously- Excerpt
“"Hip instability is common in infants, with a prevalence of 1% to 1.5% and an incidence rate of 5 per 1,000 in boys and 13 per 1,000 among girls. Approximately 90% of neonatal hips with instability or mild dysplasia resolve spontaneously." ”
- Source data from
- 2024-02-12
- Accessed
- 2026-04-18 · archived copy
- Calculation
- StatPearls provides the prevalence anchor and the critical spontaneous- resolution figure: 90% of neonatal hip instability resolves without intervention. This means the denominator of infants who actually need treatment is ~10% of those with detectable instability, or roughly 1-3 per 1,000 live births. The high spontaneous resolution rate is why some screening programs recommend watchful waiting for mild instability detected at birth.
-
[2] Journal of Children's Orthopaedics (PMC) — Treatment of developmental dysplasia of the hip with the Pavlik harness in children under six months of age: indications, results and failures
Treatment of developmental dysplasia of the hip with the Pavlik harness in children under six months of age: indications, results and failures- Statistic
Pavlik harness success rate 90-96% when initiated before 3 months of age; 71% overall success rate across all ages under 6 months- Excerpt
“"The success rate of this algorithm was reported to be 96% in infants under the age of four weeks and more than 90% in infants under the age of three months." ”
- Source data from
- 2018-08-01
- Accessed
- 2026-04-18 · archived copy
- Calculation
- Omeroglou 2018 provides the treatment-success data that defines the other side of the risk equation. When DDH is detected early (under 3 months), Pavlik harness treatment succeeds in >90% of cases with very low residual dysplasia (2.81%). The key implication: the fear should not be about DDH existing, but about it being missed. Early detection + Pavlik harness is essentially curative.
-
[3] Cureus (PMC) — Developmental Dysplasia of the Hip (DDH): Etiology, Diagnosis, and Management
Developmental Dysplasia of the Hip (DDH): Etiology, Diagnosis, and Management- Statistic
DDH is the main cause of total hip replacement in young people (21-29% of THR under age 50); untreated DDH leads to premature degenerative changes by skeletal maturity- Excerpt
“"Failure to identify and treat developmental dysplasia of the hip can lead to functional disability, hip pain, and accelerated osteoarthritis. DDH is the main cause of THR in young people (about 21% to 29%)." ”
- Source data from
- 2023-09-07
- Accessed
- 2026-04-18 · archived copy
- Calculation
- This 2023 review provides the consequence data for missed DDH. The 21-29% figure for young-adult THR attributable to DDH represents the cumulative impact of historically missed cases. As screening has improved, this proportion is expected to decline — but it anchors the severity estimate for cases that do slip through.